Rs612709 in ADAM33 showed protective effect and was rated as strong evidence of association with COPD in both “diverse populations” (OR = 0.60, 95% CI = 0.52−0.68) and Caucasians (OR = 0.64, 95% CI = 0.53−0.77). Here, ADAM33 is linked to chronic obstructive pulmonary disease.